Current quality assurance approacheswill not be adequate to satisfy the needs for quality in the next decade. Quality management science (QMS), as evolvingin industrytoday, providesthe dynamic framework necessaryto providecontinuousimprovementof quality.QMS emphasizesthe importance of defining quality goals based on the needs and expectations (implied needs) of customers.The laboratory can developcustomer-friendlygoals and measuresof quality by recognizingthat customers'experiencesare represented by a totalityof results.Qualitygoals and measures are best communicatedas "total performance" by specifyinga limit and percentile of the distribution,rather than a mean and standard deviation. Applicationof quality goals within the laboratory will usually require partitioningthe total performance goal into componentsand translatingthose componentsinto specificationsto guidethe operationand management of productionprocesses. QMS also extends beyond technical processes to people processesand providesguidance for improvingthe qualityof worklifeand caring for the laboratory'smost essential resource-our people.
Quality management
science (QMS) offers new opportunities for improving the quality of health care.3 According to Laffel and Blumenthal (1), the traditional quality assurance (QA) approaches in health care have several limitations: (a) the definition of quality is too narrow, focusing on the patient as the only customer; (b) the objective is often to achieve norms representing current performance, rather than satisfying the real needs of customers; (c) the target for improvement is primarily physician practice and behavior, rather than the performance of the organization as a whole; and (d) performance tends to be restricted to technical matters and does not adequately consider the delivery of services.
In contrast, modern industrial QMS broadens the definition of customers so that physicians and nurses are considered a laboratory's immediate customers, even though the patient is the ultimate customer. QMS emphasizes the continuous improvement of quality and targets processes rather than people as the source of problems. People are 'Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI 53792.
2Depwtment of Pathology and Laboratory Medicine, Division of Clinical Chemistry, Hartford Hospital, Hartford, CT 06115.
3Nonstandard abbreviations: QMS, quality management science; QA, quality assurance; QLP, quality laboratory practices; QC, quality control; QI, quality improvement; QP, quality planning; JCAHO, Joint Commission for Accreditation of Healthcare Organizations; and NCEP, National Cholesterol Education Program.
Received April 6, 1990 ; accepted July 30, 1990.
1712 CLINICALCHEMISTRY, Vol. 36, No. 10, 1990 considered to be an organization's primary resource and are to be continually developed through training and education. QMS provides participatory mechanisms (project teams, quality circles, suggestion programs) to involve everyone in problem solving and quality improvement. In this way, quality becomes a pervasive issue that extends beyond technical performance to organizational effectiveness in the delivery of service. Quality becomes the culture of the organization and is reflected by all its people and all their actions.
Berwick (2) explains the need for QMS by describing our current management philosophy as the "theory of bad apples." In this approach, managers collect and analyze data and blame problems on the people who are doing the work. The strategy for improving quality is to weed out the bad apples. According to Berwick, health care organizations must abandon this approach and focus instead on the continuous improvement of quality. To implement this, he recommends that (a) managers become leaders in advocating continuous improvement; (b) investments in education and training be made to support continuous improvement; (c) respect and recognition be provided for all health care workers; (d) an open dialogue be maintained between customers and suppliers; (e) the tools and techniques of modern industrial QMS be applied; and (t) organizational structures be modified to provide a central role for quality engineers or quality management scientists. To involve all staff members in the mission of quality improvement, he strongly suggests the adoption of the "project team" as a new flexible organizational component.
Application of the principles of industrial QMS in clinical laboratories begins by focusing on customers-"customerizing the clinical laboratory" is the terminology used by Schuler (3). According to Schuler, we and our staffs must be reoriented to think about customers; O'Connor emphasizes that this reorientation should start by recognizing the needs and expectations of our own "internal" customers (4). We must constantly gather information from customers to assess their needs and expectations, and to identify the level of performance they deem necessary. Our jobs are to design our delivery systems to provide the services they need.
We must recognize that our customers outside the la ratory are many; they include patients, physicians, nurses administrators, other departments, external regulate agencies, and payors. According to O'Connor (4), our tomers judge the quality of our services not by reliabili alone, but also by responsiveness, competence, access, cour tesy, communication, credibility, security, understandi consumer needs, and other tangibles such as facilities equipment, and the appearance of personnel. Therefore, th quality of our services depends on providing a "totality o features and characteristics that conform to the stated o mplied needs of [these] users or customers" (5) . To do our obs well, we must understand our customers' needs and xpectations and establish quality goals that guide the Jesign, evaluation, implementation, and operation of the laily laboratory testing processes.
Our purpose in this paper is to describe how the indusnal model for QMS can be adapted to clinical laboratories n provide a logical framework for managing the quality of early everything we do We discuss meaningful measures )f quality characteristics to illustrate the differences beween our traditional perspective as a supplier of laboraory services and the perspective of our customers. We ruggest some general guidelines for measuring quality and gays of formatting quality goals to facilitate communicaion with our customers. Finally, we describe how quality goals should be used in managing laboratory processes and iow they redirect our scientific thinking into the realm of ilanning and delivery of laboratory services.
Framework for Managing Quality
The traditional model for quality management in clinical aboratories usually includes three major components. (a) uality aboratozy practices (QLP) provided a foundation of )olicies, procedures, and protocols that set forth the laboatory's production processes. (b) Quality control (QC) was idded in the 1960s to provide a statistical tool to monitor he performance of analytical processes, to identify probems, and to correct errors before delivery of test results to he customers. (c) Quality assurance (QA) concepts were idded in the 1980s to extend th measuring and monitorng to other quality characteristics, such as turnaround ;ime, sample identification and labeling, test utilization, 'tc.
For most of us, QA practices have tended to follow the itandards and required characteristics of the Joint Comnission for Accreditation of Healthcare Organizations JCAHO), which unfortunately have mainly perpetuated he "bad apple" philosophy. The stated objective of "menuring and monitoring the quality and appropriateness of iervices" (6) has encouraged development of paper prorams. Volumes of data are collected, analyzed, reviewed, md passed from one department and (or) committee to mother. An accumulation of stacks of paper provides locumentation of QA, whether or not the documented roblems are actually solved. Most of the problems identiled by this measuring and monitoring are inherently omplex problems involving processes that cross departnental lines. Industrial QMS has shown that solving such roblems requires a structured group problem-solving aproach, such as a quality improvement team. No such echanism currently exists in most health care organizaSons, yet JCAHO neither checks for nor recommends the am approach for problem solving. In our opinion, current commendations by JCAHO are wholly inadequate for suring quality. By overemphasizing documentation and Lisdirecting our efforts, they may actually impose a barer to the development of the quality management sysms needed to improve quality. It is essential for us to understand that QA, like QC, is ttended to measure whether the laboratory processes are thieving their goals. The difference between QC and QA is merally related to the particular quality characteristic rat is being measured. QC monitors performance characristics of the analytical process within the laboratory, .g., imprecision and inaccuracy; QA measures performance characteristics that extend the process beyond the borders of the laboratory to the areas of direct and immediate concern of our customers, e.g., turnaround time. Although both QC and QA can identify problems, neither includes a mechanism for solving the problems. Problems identified by QC tend to be solvable because they reside within our control in the laboratory and we, as laboratory scientists, have the technical expertise to solve them. Problems identified by QA are best solved by assembling the necessary across-department expertise in the form of the "quality team"-a missing element in our current quality system.
In fact, two additional components-quality improvement (QI) and quality planning (QP)-are needed for quality to be properly managed (7) . A fully developed framework for quality management should include the "5 Qs" shown in Figure 1 , which should function as a continuous feedback loop to provide the dynamic process necessary to manage quality in today's fast-changing, competitive health care environment.
General guidelines for development and implementation of QI in a health care laboratory have been described (8). The QI component complements QA by providing the structured mechanism necessary to solve problems that extend across laboratory sections or hospital departments, or extend across different professional groups, such as medical technologists, clinical chemists, clinical pathologists, nurses, pharmacists, and physicians. Solving such problems requires the quality team approach because no one person, profession, section, or department has the knowledge and skills to identify the cause or to develop and implement the solution. New problem-solving techniques are used to diagnose problems, identify remedies, and replan the processes to prevent problems from recurring. Implementation requires an investment in training and education, initially for top and middle managers who steer the improvement process, then for individuals participating in the quality teams, and ultimately for everyone in the organization.
QI also requires a cultural change that encourages cooperative efforts, recognizes team accomplishments, and rewards individuals for being good team members. In our present organizations, individuals tend to get ahead primarily by standing out from the group, not by contributing to a team. For teamwork to thrive, we must value the contributions of each individual to the group effort, encour- age their involvement by establishing participative mechanisms for problem solving, support their efforts through training and education, and celebrate their accomplishments as team members. QI requires a people-oriented organization because everyone needs to be seriously involved and committed to solving our many problems. Whereas QI leads to solving problems by replanning processes, the ultimate objective, of course, is to prevent problems from occurring by planning processes correctly in the first place. Thus, the QP component must be added to complete the quality management framework. QP provides the focus on customers, emphasizes the importance of understanding their needs and expectations, and leads to the definition of quality goals. These quality goals guide the planning of new processes, the implementation of operational policies and procedures (QLP), the measuring and monitoring of performance to assure that quality is satisfactory (QC and QA), and the solving of problems to improve quality when performance is not satisfactory (QI). The last step leads to replanning the process and repeating the cycle of implementation, measuring and monitoring, and improvement. This provides continuous improvement of quality through a dynamic management framework that has quality goals for central guidance.
Customer vs Supplier Perspectives on Quality
We must communicate with our customers to assess whether satisfactory quality is being achieved. However, we must not underestimate the difficulties in communication caused by the different perspectives of the customer and supplier. For example, the turnaround time of a test is often viewed very differently by the physician and the laboratory. The physician's "clock" may start as soon as he or she has written an order for a test and will not stop until the results are seen. The laboratory's clock starts only after the order to draw the specimen is received-or even later, when the specimen arrives for processing-and stops when the test result is reported (entered into the laboratory or hospital information system or called to the ordering source). There is an obvious difference in perspectives, and we should expect problems to occur just because of these different points of view.
More subtle differences in perspectives may also have an effect. This value of 7 min representl the best single or point estimate of the time it takes th laboratory to provide this service. The laboratory staff may communicate to its customers that it takes an average of ' mm to perform this analysis. However, the customers dc not experience this average performance-they ezperienc the performance for individual samples, which are abovE and below the average, anywhere in the observed distribu. tion of turnaround times. In this case, even if the labora. tory achieves a goal of average performance better than. say, 15 mm, complaints about quality of service may lx expected. The cumulative distribution shows that about 15% of the samples are not reported by 15 mm and 5% ar still not reported by 25 mm. From the customers' point 01 view, performance is not adequately described by the aver age (or median). More important information is containec in the tail of the distribution than in the peak. From thE customer's viewpoint, the times corresponding to the 90tl to 95th percentiles are more appropriate for establishing s quality goal and monitoring performance than is the aver age turnaround time. Analytical quality provides another example of the dif ference in perspective of the laboratory and its customers, According to a published recommendation from the Na. tional Cholesterol Education Program (NCEP), methods ol measuring cholesterol currently should have a bias of 5% oi less and a CV of 5% or less at concentrations of 2000-2400 mg/L (9). Americans have been encouraged by the NCEP tc know their cholesterol concentration and are engaged is widespread testing at various testing sites, including hospitals, clinics, pharmacies; and shopping malls. Changes oJ 50-100 mg/L may be interpreted by the public as significant, even though such changes are well within the expected within-subject biological variation, as well as withis the analytical limits allowed by NCEPs 5% goals. lyzed by a method that just satisfies the quality goals Assuming that the 5% inaccuracy is positive, the averag concentration observed will be 2100 mg/L and 50% of th#{128} measurements will be in error by at least 100 mg/LU Because of the added effects of imprecision, 16% will havE errors greater than 200 mg/L, 2.3% will exceed 300 mg/L, and 0.135% (4 of 3000) will exceed 400 mg/L.
One could argue that these individuals do not (or should not) interpret their test results-this should be done by 40 170 Fig. 3 . Distribution of analytical errors for a cholesterol method ju satisfying qualitygoalsof 5% bias and 5% CV their physicians. Unfortunately, even though physicians ire more sophisticated customers, many of them also find mprecision and inaccuracy to be foreign concepts. Physiians experience the combined effect of these errors, or the 'total error" (10), which will be much larger than is Lmmediately apparent from the 5% goals stated by NCEP. In other words, the NCEP goals are not in customerilendly terms; communication with our customers is imaired when quality goals are stated in terms of inaccuracy md imprecision, rather than stated directly as the total irror that may be observed.
umuIative Distribution and Customer-Friendly Quality 3oals
Because it is important to appreciate the customers' Derspective as a collective experience with a distribution of results, it is therefore appropriate to provide collective neasures of quality by presenting a cumulative distribuion or by stating the limits and corresponding percentiles that describe the tail of the distribution. Furthermore, we ;hould define quality goals for "total performance" by 3tating the limit and percentile of the cumulative distribuion instead of figures for average performance.
For turnaround time, 90th or 95th percentile limits are robably adequate for describing within-laboratory perfornance. Use of higher limits, e.g., 99%, tends to focus ittention on a few extraordinary problems, rather than on the performance to be expected in routine daily operations. 'or the blood gas data in Figure 2 , for example, turnaround thnes >15 mm were associated with batch arrival of pecimens, repeat analyses, instrument problems, or heavy workload. This information is primarily of value for initiiting specific quality-improvement efforts to improve perrmance, not for describing routine performance. In the case of analytical quality, the errors expected snder stable operating conditions are predictable from the aussian model. We believe it is useful to adopt a 99.7% Limit (±3s limits) as the requirement for relating method performance to the "allowable total error." In other words, method inaccuracy and imprecision should be sufficiently unall so that the bias together with 3s is less than the total mrror deemed allowable. Use of a 99.7% limit is more onservative than the usual 95% limit (±2s) that was recommended many years ago (10). However, allowing 1 of 0 results to exceed a quality goal is not a very good arantee of quality. It is doubtful that we ourselves would ccept such a limited warranty in the products and services or which we are the customers. A minimal warranty would to allow only 1 of 100 to exceed the quality requirement ±2.58s limits), but a better target would be to allow only 3 f 1000 to exceed the limit (±3s limits). The principle of ntinuous improvement indicates that we should move in s direction, a step at a time if necessary, but certainly eting this level of performance for our fourth-and h-generation analytical systems. Guidelines for other quality characteristics need to be valuated on an individual basis. Communication with ustomers will generally be improved if we use cumulative stributions for presenting measures of quality and state uality goals as a limit and percentile of the distribution.
artitioning and Translating the Total Performance Quality oal
The preceding arguments for defining a limit of the stribution as a total performance quality goal have been based primarily on the customers' perspective. However, a total performance goal is also useful for managing production processes. The laboratory scientist must assume responsibility for partitioning the total requirement into components for different parts or steps of the process and for translating the components into specifications appropriate for that part or step of the process. Quality goals are different from process specifications. Process specifications depend on our further professional interpretation, judgment, and plan (design) for achieving the quality goal.
For turnaround time, for example, it is useful to identif' the steps in the process, as illustrated in Figure 4 (left side) . Requirements for within-laboratory turnaround time may be partitioned over specimen acquisition, processing, analysis, and reporting. Individual specifications are required for each step if one is to manage the overall process; however, the specifications may vary from one laboratory to another, depending on their particular process and how they can best achieve the required performance. In all steps the component specifications are probably best formatted as maximum limits for time (t,,) .
For analytical quality (Figure 4 , right side), the total error requirement (TEa) may include components from inaccuracy and imprecision of the method, calibration uncertainty, and the lack of sensitivity of the statistical QC procedure (11). Translation may be more difficult because different kinds of specifications are needed to evaluate and control different sources of error. Inaccuracy requires a specification in the form of an allowable bias; imprecision requires a specification in the form of an allowable standard deviation. Calibration generally introduces a systematic error, which may be specified by an allowable bias when calibration occurs very infrequently, or specified by an allowable standard deviation when calibration occurs daily or more frequently.
For selection or design of QC procedures, it is useful to have a specification of the medically critical systematic error (SE) that needs to be detected (12) . Additional components may be considered when it is necessary to allow for within-subject biological variability, sampling variability, sampling bias, and analytical bias between different routine methods operating simultaneously in a laboratory.
Discussion
Clinical laboratory scientists have a unique opportunity to provide leadership in the area of QMS for our organiza- 4 . Application of quality goals for designing and managing two characteristics of the laboratory testing process: turnaround time and analytical error tions and for health care in general. The concepts of industrial QMS can probably be more easily adopted in clinical laboratories than in any other unit in a health care organization.
We have a strong foundation of quality practices (QLP), extensive experience in statistical quality control (QC), and strong data-analysis skills for measuring and monitoring quality (QA). Although our training leads to a focus on analytical processes, we need to expand our view to include across-department processes and extend our scientific thinking to the management of those larger processes.
Given our current strengths (QLP, QC, QA) and our insights into the need for additional components QI and QP, we are able to develop the dynamic framework necessary to manage quality objectively. That framework is simply a logical extension of the scientific method we use in our technical work. We plan studies (QP), do experiments (QLP), collect data (QC, QA) , analyze what needs to be done next (QI), and then repeat the whole cycle, again and again, until we achieve our goals. We need to apply this continuous improvement thinking to all our processes and to progressively expand the areas in which we apply the scientific method.
In applying the scientific method, we need to recognize that objectivity depends on having clearly defined quality goals to guide the whole management process. Quality goals are needed for planning new production processes, implementing new policies and procedures, measuring and monitoring performance, and assessing the need for improvements. The quality of our production processes can be managed objectively when quality goals are partitioned and translated into appropriate specifications for each component or step of the process.
Quality goals are, in effect, the "standards" needed to advance from subjective or qualitative management to objective or quantitative management. They are needed to standardize new processes so that the necessary quality will be achieved when the process is first implemented; to assess raw measurements of performance for assuring quality; to convert performance data into diagnostic information for problem solving and quality improvement; and to provide stability and consistency over time. Like standards, quality goals must be carefully prepared if they are to be useful. We believe the proper format is a total performance limit that contains a specified percentage of the distribution (expressed as percentiles). Unfortunately, many of the recommendations on quality goals now found in the literature do not readily lend themselves to laboratory applications because they are improperly formatted. A clear understanding of how goals are to be used and communicated to our customers is necessary to improve our efforts in defining them.
Although we see many implications of QMS for the technical management of testing processes in clinical laboratories, we think it is equally important to consider the implications for "people processes." Continuous improvement also means the ongoing development of our major enduring resource-people.
This requires a serious investment in in-service training and continuing education, as well as a commitment to formal educational processes for clinical laboratory personnel at all levels. To attract new people to the field and to retain our present staff, we mus make the laboratory an interesting and meaningful plan to work, not just an efficient production line. We mus provide an environment and culture that stimulate think ing, not ones that just stress physical and mental endux ance. We must provide opportunities for growth and devel opment, not just added responsibilities and frustrationE We must allow people to participate in decisions that affec the quality of their work and their working conditions. Ii short, we must "care" for the people with whom we work i they are to care about the quality of the services the: deliver.
In a broad sense, "caring for quality" must become thi central focus in what we do in the clinical laboratory. Lik any philosophy, it will provide a framework of values an beliefs that will guide our actions. Like religion, it will b most meaningful when it affects our everyday activities Like mythology, it will put us in touch with the deepe things that matter. Quality in health care matters. Th personal commitment of each of us is necessary to ensur that quality is a vital force guiding our activities instead o a mere paper program diverting our efforts from meaning ful work. We must care for quality today if we are to b recipients of quality care tomorrow.
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